Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.37 |
| ▸ | AKR1B10 | O60218 | 5/20 | 0.36 |
| ▸ | AKR1B1 | P15121 | 5/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | TTR | P02766 | 1/20 | 0.34 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
| ▸ | BTK | Q06187 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9764056 | 0.91 | HCAR2 (0.38) | HCAR2AKR1B10AKR1B1ALOX5MAPT | |
| SCHEMBL5898832 | 0.88 | HCAR2 (0.38) | HCAR2AKR1B10AKR1B1ALOX5MAPT | |
| SCHEMBL9763748 | 0.88 | HCAR2 (0.35) | HCAR2AKR1B10AKR1B1ALOX5MAPT | |
| SCHEMBL16205162 | 0.87 | HCAR2 (0.37) | HCAR2AKR1B10AKR1B1ALOX5MAPT | |
| SCHEMBL22092326 | 0.84 | HCAR2 (0.40) | HCAR2AKR1B10AKR1B1ALOX5MAPT | |
| SCHEMBL4623580 | 0.84 | HCAR2 (0.40) | HCAR2AKR1B10AKR1B1ALOX5MAPT | |
| SCHEMBL16205020 | 0.83 | HCAR2 (0.38) | HCAR2AKR1B10AKR1B1ALOX5MAPT | |
| SCHEMBL7794491 | 0.83 | HCAR2 (0.39) | HCAR2AKR1B10AKR1B1ALOX5MAPT | |
| SCHEMBL17373023 | 0.82 | HCAR2 (0.41) | HCAR2AKR1B10AKR1B1ALOX5MAPT | |
| SCHEMBL17287255 | 0.82 | HCAR2 (0.41) | HCAR2AKR1B10AKR1B1ALOX5MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1945231-B1 | CONFORMABLE SOLVENT-BASED BANDAGE AND COATING MATERIAL | ROCHAL PARTNERS LLP (US) | 2021-11-10 | — | — | EP | claimed |
| EP-2764065-B1 | SACRIFICIAL ADHESIVE COATINGS | ROCHAL IND LLC (US) | 2017-03-22 | — | — | EP | claimed |
| US-8784793-B2 | Conformable solvent-based bandage and coating material | ROCHAL INDUSTRIES, LLP (US) | 2014-07-22 | — | — | US | claimed |
| US-20130303654-A1 | CONFORMABLE SOLVENT-BASED BANDAGE AND COATING MATERIAL | ROCHAL INDUSTRIES LLP (US) | 2013-11-14 | — | — | US | claimed |
| US-8263720-B1 | Sacrificial adhesive coatings | ROCHAL INDUSTRIES, LLP (US) | 2012-09-11 | — | — | US | claimed |
| US-8197803-B2 | Method of forming a conformable solvent-based bandage and coating material | ROCHAL INDUSTRIES, LLP (US) | 2012-06-12 | — | — | US | claimed |
| US-20120114729-A1 | SILICONE-PEROXIDE COMPOSITIONS FOR LONG-TERM, CONTROLLED OXYGEN RELEASE | UNIVERSITY OF MIAMI (US) | 2012-05-10 | — | — | US | claimed |
| WO-2010121024-A2 | SILICONE-PEROXIDE COMPOSITIONS FOR LONG-TERM, CONTROLLED OXYGEN RELEASE | UNIVERSITY OF MIAMI (US) | 2010-10-21 | — | — | WO | claimed |
| US-20090210002-A1 | METHOD OF FORMING A CONFORMABLE SOLVENT-BASED BANDAGE AND COATING MATERIAL | ROCHAL INDUSTRIES LLP (US) | 2009-08-20 | — | — | US | claimed |
| EP-1945231-A2 | CONFORMABLE SOLVENT-BASED BANDAGE AND COATING MATERIAL | Salamone, Ann Beal (US) | 2008-07-23 | — | — | EP | claimed |
| WO-2007022377-A2 | CONFORMABLE SOLVENT-BASED BANDAGE AND COATING MATERIAL | SALAMONE ANN BEAL (US) | 2007-02-22 | — | — | WO | claimed |
| US-20070041935-A1 | Polymerizable cyanoacrylate monomer and volatile liquid selected from linear and cyclic siloxanes, polydimethylsiloxanes, isooctane, and octane; kits | ROCHAL PARTNERS LLP | 2007-02-22 | — | — | US | claimed |
| US-11839626-B2 | Composition and kits for inhibition of pathogenic microbial infection and methods of using the same | ROCHAL TECHNOLOGIES LLC (US) | 2023-12-12 | — | — | US | disclosed |
| EP-1945231-B1 | CONFORMABLE SOLVENT-BASED BANDAGE AND COATING MATERIAL | ROCHAL PARTNERS LLP (US) | 2021-11-10 | — | — | EP | disclosed |
| EP-3220741-B1 | COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME | ROCHAL IND LLC (US) | 2021-02-24 | — | — | EP | disclosed |
| EP-3052140-B1 | NON-SELF-ADHERENT COATING MATERIALS | ROCHAL IND LLC (US) | 2019-05-01 | — | — | EP | disclosed |
| EP-1465903-A1 | HIGH REFRACTIVE INDEX POLYMERIC SILOXYSILANE COMPOSITIONS | BAUSCH & LOMB INCORPORATED (US) | 2004-10-13 | — | — | EP | disclosed |
| EP-1448572-A1 | HIGH REFRACTIVE INDEX POLYMERIC SILOXYSILANE COMPOSITIONS | BAUSCH & LOMB INCORPORATED (US) | 2004-08-25 | — | — | EP | disclosed |
| WO-2003040157-A1 | HIGH REFRACTIVE INDEX POLYMERIC SILOXYSILANE COMPOSITIONS | BAUSCH & LOMB INCORPORATED (US) | 2003-05-15 | — | — | WO | disclosed |
| WO-2003040158-A1 | HIGH REFRACTIVE INDEX POLYMERIC SILOXYSILANE COMPOSITIONS | BAUSCH & LOMB INCORPORATED (US) | 2003-05-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11839626-B2 | Composition and kits for inhibition of pathogenic microbial infection and methods of using the same | CUTA, MMP8, MMP1 | HCAR2 3862/4885AKR1B10 2122/4885AKR1B1 3174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.